In 2008, Dr. Sudhir Paul, a chemical immunologist from the University of Texas at Houston, announced his discovery of a novel way to destroy HIV.
His new HIV E-vaccine would teach the body to create Abzymes—electrically charged antibodies-that target and neutralize the non-mutating parts of the ever-changing HIV virus. This new paradigm challenges much of the existing work in the field. It was met with backlash from the scientific community. Peer reviewed grants from the National Institute of Health, which had funded Dr. Paul’s research with over $15 million, all but disappeared.
That same year, Zachary Barnett, Founder and Executive Director of Abzyme Research Foundation (ARF), was diagnosed as HIV positive.
While researching treatment online, he came across a clip from CBS News on Dr. Paul’s work entitled “Possible HIV Cure.” Inspired to take action, Barnett wrote Dr. Paul a small check and proposed throwing a fundraising event in New York City. When Dr. Paul called him two weeks later, a partnership was formed.
The partnership between ARF and Dr. Paul has grown over the years into a coalition of world-class doctors and scientists, dedicated activists and artists — people willing to take a stand for our future by raising awareness and funds for this vital research. The scientific team, lead by Dr. Paul, has developed the only vaccine candidate documented to produce broadly neutralizing antibodies that are effective against most strains of HIV. Our HIV E-Vaccine is now one step away from FDA permission to begin human trials.